Start | Grid View | Browse by Day OR Group/Topical | Author Index | Keyword Index | Personal Scheduler

Evolution of QbD From a Drug Substance Scientist's Perspective

Monday, October 17, 2011: 10:20 AM
Symphony III (Hilton Minneapolis)
Timothy J. Watson, Pfizer Inc, Groton, CT

tobe added

Extended Abstract: File Not Uploaded
See more of this Session: QbD Plenary
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture